1. Home
  2. EDUC vs CMMB Comparison

EDUC vs CMMB Comparison

Compare EDUC & CMMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Educational Development Corporation

EDUC

Educational Development Corporation

N/A

Current Price

$1.06

Market Cap

8.9M

ML Signal

N/A

CMMB

Chemomab Therapeutics Ltd.

N/A

Current Price

$1.13

Market Cap

8.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
EDUC
CMMB
Founded
1965
2004
Country
United States
Israel
Employees
N/A
N/A
Industry
Consumer Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.9M
8.4M
IPO Year
1995
2023

Fundamental Metrics

Financial Performance
Metric
EDUC
CMMB
Price
$1.06
$1.13
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
★ $15.00
AVG Volume (30 Days)
17.4K
★ 33.6K
Earning Date
10-14-2026
11-19-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 142.86
101.67
EPS
N/A
★ 0.04
Revenue
★ $22,913,600.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
$28.00
Revenue Growth
N/A
★ N/A
52 Week Low
$0.99
$0.92
52 Week High
$1.65
$3.07

Technical Indicators

Market Signals
Indicator
EDUC
CMMB
Relative Strength Index (RSI) 24.37 30.87
Support Level $0.99 $1.05
Resistance Level $1.36 $1.91
Average True Range (ATR) 0.08 0.12
MACD -0.00 0.02
Stochastic Oscillator 21.57 34.68

Price Performance

Historical Comparison
EDUC
CMMB

About EDUC Educational Development Corporation

Educational Development Corp distributes books and educational products and publications through its PaperPie and EDC Publishing divisions to individual consumers, book, toy and gift stores, libraries and home educators located throughout the United States. The company is the owner and exclusive publisher of Kane Miller children's books; Learning Wrap-Ups, maker of educational manipulatives; and SmartLab Toys, maker of STEAM-based toys and games. Multi-Level Marketing (MLM) distributor of Usborne Publishing Limited (Usborne) children's books. It sell children's books, educational toys and games and other related products. It has two reportable segments: PaperPie and Publishing of which majority of revenue comes from Paperpie Segment.

About CMMB Chemomab Therapeutics Ltd.

Chemomab Therapeutics Ltd is a clinical-stage biotechnology company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs. The company's candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin, and lung fibrosis using a novel and differentiated mechanism of action. CM-101 has demonstrated the potential to treat multiple severe and life-threatening fibrotic and inflammatory diseases.

Share on Social Networks: